Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium

Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium

Abstract Treatment of Burkitt Lymphoma/Leukemia (BL/L) in adults has evolved from the use of pediatric inspired regimens (CODOX-M/IVAC, hyper-CVAD, GMALL) to the use of lower intensity EPOCH regimens. The addition of rituximab has led to improvements in overall survival. Survival with these regimens...

Full description

Saved in:
Bibliographic Details
Main Authors: Akhil Rajendra, Manju Sengar, Anu Korula, Prasanth Ganesan, Hasmukh Jain, Divya K, Prasanna Samuel, Jayachandran Perumal Kalaiyarasi, Gaurav Prakash, M. Joseph John, Rasmi Palassery, Chandran K. Nair, Tanuja Shet, Sushil Selvarajan, Lingaraj Nayak, Parathan Karunakaran, N. A. Fouzia, Om Prakash, Bhausaheb Bagal, Nikita Mehra, Saranya Kumaran, Sridhar Epari, Jayshree Thorat, Venkatraman Radhakrishnan, Aby Abraham
Format: Article
Language:English
Published: Nature Publishing Group 2025-03-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-025-01240-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41408-025-01240-w

Similar Items